BackDaBomb Protein Biotech Overview

DaBomb Protein Biotech Current Cash

Latest current cash for 6578.TWO: $140M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$139.81M
↓ 37.28% YoYΔ $-83.11M vs prior year quarter

Peer trimmed avg / median

Loading

DaBomb Protein Biotech Current Cash History

Loading

DaBomb Protein Biotech vs. peers: Current Cash Comparison

Loading

DaBomb Protein Biotech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DaBomb Protein Biotech (6578.TWO) FAQ

As of the most recent data (June 2026), 6578.TWO shows a current cash of $140M. That compares with $220M in the prior-year period — down 37.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6578.TWO's current cash is now $140M (was $220M) — a 37.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether DaBomb Protein Biotech is outperforming or lagging.

Tracking 6578.TWO's current cash over time shows whether DaBomb Protein Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $220M in the prior-year period — down 37.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has DaBomb Protein Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $140M) with ownership activity and broader fundamentals.